Monthly Archives: March 2019

Oppenheimer Maintains a Hold Rating on Alliance Data Systems (ADS)

Oppenheimer analyst Dominick Gabriele maintained a Hold rating on Alliance Data Systems (ADS – Research Report) yesterday. The company’s shares closed on Friday at $174.98. Gabriele said: “In our note Deconstructed, dated 1/28/19, we provided investors a template and our

SunTrust Robinson Reaffirms Their Buy Rating on Facebook (FB)

SunTrust Robinson analyst Youssef Squali maintained a Buy rating on Facebook (FB – Research Report) yesterday and set a price target of $210. The company’s shares closed on Friday at $166.69. Squali commented: “We were not surprised by the content

Susquehanna Keeps a Buy Rating on Foot Locker Inc (FL)

In a report released today, Sam Poser from Susquehanna maintained a Buy rating on Foot Locker Inc (FL – Research Report), with a price target of $80. The company’s shares closed on Friday at $60.60. According to TipRanks.com, Poser is

Atara Biotherapeutics (ATRA) Receives a Buy from Mizuho Securities

In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on Atara Biotherapeutics (ATRA – Research Report), with a price target of $62. The company’s shares closed on Friday at $39.75. According to TipRanks.com, Syed is

Oppenheimer Maintains Their Buy Rating on Amazon (AMZN)

In a report released today, Jason Helfstein from Oppenheimer maintained a Buy rating on Amazon (AMZN – Research Report), with a price target of $2085. The company’s shares closed on Friday at $1780.75. Helfstein commented: “Raising target to $2,085 (from

Cowen & Co. Keeps a Buy Rating on Molecular Templates Inc (MTEM)

In a report issued on March 29, Boris Peaker from Cowen & Co. maintained a Buy rating on Molecular Templates Inc (MTEM – Research Report). The company’s shares closed on Friday at $5.81. According to TipRanks.com, Peaker is a 4-star